​
​

Twist Bioscience (TWST) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Twist Bioscience Revenue Highlights

Latest Revenue (Y)

$245.11M

Latest Revenue (Q)

$81.46M

Main Segment (Y)

Ngs Tools

Main Geography (Y)

Americas

Twist Bioscience Revenue by Period

Twist Bioscience Revenue by Year

DateRevenueChange
2023-09-30$245.11M20.41%
2022-09-30$203.56M53.83%
2021-09-30$132.33M46.87%
2020-09-30$90.10M65.67%
2019-09-30$54.38M113.89%
2018-09-30$25.43M136.16%
2017-09-30$10.77M374.53%
2016-09-30$2.27M-

Twist Bioscience generated $245.11M in revenue during NA 2023, up 20.41% compared to the previous quarter, and up 963.97% compared to the same period a year ago.

Twist Bioscience Revenue by Quarter

DateRevenueChange
2024-06-30$81.46M8.18%
2024-03-31$75.30M5.32%
2023-12-31$71.50M6.80%
2023-09-30$66.95M5.03%
2023-06-30$63.74M5.92%
2023-03-31$60.18M10.95%
2022-12-31$54.24M-5.34%
2022-09-30$57.31M2.13%
2022-06-30$56.11M16.59%
2022-03-31$48.13M14.54%
2021-12-31$42.02M10.72%
2021-09-30$37.95M8.38%
2021-06-30$35.02M12.22%
2021-03-31$31.20M10.81%
2020-12-31$28.16M-13.17%
2020-09-30$32.43M52.93%
2020-06-30$21.21M9.90%
2020-03-31$19.30M12.43%
2019-12-31$17.16M9.07%
2019-09-30$15.74M15.71%
2019-06-30$13.60M0.32%
2019-03-31$13.56M17.97%
2018-12-31$11.49M36.70%
2018-09-30$8.41M28.53%
2018-06-30$6.54M6.08%
2018-03-31$6.17M42.96%
2017-12-31$4.31M24.44%
2017-09-30$3.47M-

Twist Bioscience generated $81.46M in revenue during Q3 2024, up 8.18% compared to the previous quarter, and up 135.37% compared to the same period a year ago.

Twist Bioscience Revenue Breakdown

Twist Bioscience Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceSep 23Sep 22Sep 21Sep 20Sep 19
Antibody Discovery$23.17M$24.17M---
Dna And Biopharma Libraries$10.20M$6.15M$12.66M--
Ngs Tools$123.71M$99.31M$72.67M--
Oligo Pools$14.49M$12.42M$8.04M$4.54M$4.59M
Synthetic Genes$73.54M$61.51M$38.96M$35.19M$26.71M
DNA And Biopharma Libraries---$6.35M-
NGS Tools---$44.02M$21.04M
DNA Libraries----$2.04M

Twist Bioscience's latest annual revenue breakdown by segment (product or service), as of Sep 23: Ngs Tools (50.47%), Synthetic Genes (30.00%), Antibody Discovery (9.45%), Oligo Pools (5.91%), and Dna And Biopharma Libraries (4.16%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Oligo Pools$4.17M$3.94M$4.19M$3.74M$3.73M$3.31M$3.70M$3.67M$3.26M$2.31M$3.19M$2.67M$2.02M$1.84M$1.51M$1.20M$1.00M$1.10M$1.24M$1.31M
Synthetic Genes$24.95M$22.36M$19.73M$20.05M$19.30M$18.01M$16.18M$16.42M$17.40M$14.16M$13.53M$9.74M$11.16M$9.19M$8.87M$8.64M$9.60M$9.12M$7.84M$7.86M
Antibody Discovery$5.10M$4.70M$5.23M$3.39M$4.58M$7.03M$8.17M$6.53M$6.24M$6.59M$4.81M---------
Dna And Biopharma Libraries$3.85M$3.53M$2.94M$2.66M$2.88M$2.83M$1.84M$1.50M$1.42M$1.97M$1.26M$4.10M$3.14M$3.22M------
Ngs Tools$43.40M$40.77M$39.42M$37.11M$33.24M$28.99M$24.36M$29.19M$27.79M$23.10M$19.23M$21.45M$18.70M$16.95M------
DNA And Biopharma Libraries--------------$2.21M$2.42M$1.52M$1.35M--
NGS Tools--------------$15.57M$20.18M$9.08M$7.73M$7.03M$6.18M
DNA Libraries------------------$1.06M$382.00K

Twist Bioscience's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Ngs Tools (53.28%), Synthetic Genes (30.62%), Antibody Discovery (6.26%), Oligo Pools (5.11%), and Dna And Biopharma Libraries (4.72%).

Twist Bioscience Revenue Breakdown by Country

Annual Revenue by Country

CountrySep 23Sep 22Sep 21Sep 20Sep 19
EMEA$71.39M$62.08M$25.82M$14.69M-
Americas$151.26M$122.47M$77.91M$1.08M-
Asia Pacific$22.46M$19.01M$10.30M$5.12M$2.76M
E M E A--$44.12M--
UNITED STATES---$58.08M$35.94M
North America----$996.00K

Twist Bioscience's latest annual revenue breakdown by geography, as of Sep 23: Americas (61.71%), EMEA (29.13%), and Asia Pacific (9.16%).

Quarterly Revenue by Country

CountryJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Asia Pacific$6.49M$7.17M$6.32M$6.06M$5.66M$6.47M$4.27M$5.60M$4.83M$4.46M$4.04M$2.77M$3.10M$2.67M$1.77M$1.75M$1.18M$944.00K$1.24M$744.00K
Americas$51.39M$45.87M$43.96M$43.68M$39.02M$34.92M$33.65M$34.84M$35.80M$28.46M$22.61M$76.58M$544.00K$484.00K$302.00K$290.00K$269.00K$369.00K--
EMEA$23.58M$22.26M$21.22M$17.21M$19.07M$18.78M$16.33M$16.87M$15.48M$15.20M$9.06M$7.25M$6.39M$6.23M$5.94M$5.43M----
E M E A----------$15.37M$12.43M$12.66M$9.98M------
U------------$18.72M$18.08M------
UNITED STATES--------------$17.03M$23.14M$13.37M$11.75M$9.83M$9.37M
North America------------------$155.00K-

Twist Bioscience's latest quarterly revenue breakdown by geography, as of Jun 24: Americas (63.08%), EMEA (28.95%), and Asia Pacific (7.97%).

Twist Bioscience Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TMOThermo Fisher Scientific$42.86B$10.60B
IQVIQVIA$14.98B$3.90B
DHRDanaher$14.03B$3.40B
ICLRICON Public Limited Company$8.12B$2.09B
AAgilent$6.83B$1.58B
ILMNIllumina$4.50B$1.08B
MTDMettler-Toledo$3.79B$954.53M
WATWaters$2.96B$740.30M
EXASExact Sciences$2.50B$708.65M
NTRANatera$1.08B$439.76M
GHGuardant Health$563.95M$177.24M
CDNACareDx$280.32M$82.88M
TWSTTwist Bioscience$245.11M$81.46M
CSTLCastle Biosciences$219.79M$85.78M
PSNLPersonalis$73.48M$22.58M

TWST Revenue FAQ

What is Twist Bioscience’s yearly revenue?

Twist Bioscience's yearly revenue for 2023 was $245.11M, representing an increase of 20.41% compared to 2022. The company's yearly revenue for 2022 was $203.56M, representing an increase of 53.83% compared to 2021. TWST's yearly revenue for 2021 was $132.33M, representing an increase of 46.87% compared to 2020.

What is Twist Bioscience’s quarterly revenue?

Twist Bioscience's quarterly revenue for Q3 2024 was $81.46M, a 8.18% increase from the previous quarter (Q2 2024), and a 27.81% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $75.3M, a 5.32% increase from the previous quarter (Q1 2024), and a 25.13% increase year-over-year (Q2 2023). TWST's quarterly revenue for Q1 2024 was $71.5M, a 6.80% increase from the previous quarter (Q4 2023), and a 31.81% increase year-over-year (Q1 2023).

What is Twist Bioscience’s revenue growth rate?

Twist Bioscience's revenue growth rate for the last 3 years (2021-2023) was 85.22%, and for the last 5 years (2019-2023) was 350.69%.

What are Twist Bioscience’s revenue streams?

Twist Bioscience's revenue streams in p 23 are Antibody Discovery, Dna And Biopharma Libraries, Ngs Tools, Oligo Pools, and Synthetic Genes. Antibody Discovery generated $23.17M in revenue, accounting 9.45% of the company's total revenue, down -4.13% year-over-year. Dna And Biopharma Libraries generated $10.2M in revenue, accounting 4.16% of the company's total revenue, up 65.90% year-over-year. Ngs Tools generated $123.71M in revenue, accounting 50.47% of the company's total revenue, up 24.56% year-over-year. Oligo Pools generated $14.49M in revenue, accounting 5.91% of the company's total revenue, up 16.62% year-over-year. Synthetic Genes generated $73.54M in revenue, accounting 30.00% of the company's total revenue, up 19.56% year-over-year.

What is Twist Bioscience’s main source of revenue?

For the fiscal year ending Sep 23, the largest source of revenue of Twist Bioscience was Ngs Tools. This segment made a revenue of $123.71M, representing 50.47% of the company's total revenue.